Salt CompositionZolpidem 6.25mg
You Searched
Sove IT 6.25mg Tablet ER
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Insomnia
Customers also bought
More About Sove IT 6.25mg Tablet ER
Benefits
In Treatment of Insomnia : Insomnia is a common sleep disorder in which there is difficulty in falling or staying asleep at night. Sove IT 6.25mg Tablet ER helps treat insomnia as well as improves sleep quality. Sove IT 6.25mg Tablet ER works by slowing activity in the brain to allow sleep. This helps you relax and feel more energetic. It also helps you concentrate better and improves your quality of life.With Sove IT 6.25mg Tablet ER, your sleep problems should improve within 7 to 10 days. Apart from this, it is advisable to make some lifestyle changes to sleep better.
Side Effects
Side effects of Sove IT Tablet ERThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Sove ITDizziness Sleepiness Headache Nausea Stomach pain Memory loss Vertigo Vomiting Back pain Agitation Double vision Depression
How to use
How to use Sove IT Tablet ERFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Sove IT 6.25mg Tablet ER is to be taken empty stomach.
How it works
How Sove IT Tablet ER works Sove IT 6.25mg Tablet ER belongs to a group of medicines called non-benzodiazepine hypnotics. It has hypnotic, sedative, and anticonvulsant (manages fits) properties. It works by binding of the�GABAA�receptor chloride channel macromolecular complex (a chemical messenger) that slows the activity of the nerve cells in the brain and helps fall asleep.
Sove IT 6.25mg Tablet ER may cause excessive drowsiness with alcohol.
Sove IT 6.25mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Sove IT 6.25mg Tablet ER is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Sove IT 6.25mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Sove IT 6.25mg Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Sove IT 6.25mg Tablet ER is recommended.However, inform your doctor if you have any kidney disease.
Sove IT 6.25mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Sove IT 6.25mg Tablet ER may be needed. Doctor consultation is advised.Sove IT 6.25mg Tablet ER is generally started at a low dose in patients with mild to moderate liver disease and is not recommended in patients with severe liver disease.
What if I forget to take it?
If you miss a dose of Sove IT 6.25mg Tablet ER, skip it and continue with your normal schedule. Do not double the dose.nn
Manufacturer Address
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
References
Mihic SJ, Harris RA. Hypnotics and Sedatives. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 467-68
Stahl SM, editor. Zolpidem. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 751-54
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1519-20
Drugs.com. Zolpidem (19 Mar. 2019)
Chaves RG, Lamounier JA, et al. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Health Articles
